» Articles » PMID: 27224028

Gadolinium in Humans: A Family of Disorders

Overview
Specialties Oncology
Radiology
Date 2016 May 26
PMID 27224028
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The literature informs us that gadolinium can cause health issues. At least four major gadolinium disorders, including the two well-recognized nephrogenic systemic fibrosis and severe acute adverse event, have been identified.

Conclusion: We propose naming the histopathologically proven presence of gadolinium in brain tissue "gadolinium storage condition," and we describe a new entity that represents symptomatic deposition of gadolinium in individuals with normal renal function, for which we propose the designation "gadolinium deposition disease."

Citing Articles

The safety of magnetic resonance imaging contrast agents.

Cunningham A, Kirk M, Hong E, Yang J, Howard T, Brearley A Front Toxicol. 2024; 6:1376587.

PMID: 39188505 PMC: 11345262. DOI: 10.3389/ftox.2024.1376587.


Near-cure in patients with Gadolinium deposition disease undergoing intravenous DTPA chelation.

Semelka R, Ramalho M Front Toxicol. 2024; 6:1371131.

PMID: 39118832 PMC: 11306197. DOI: 10.3389/ftox.2024.1371131.


Deposition of Gadolinium in the Central and Peripheral Nervous Systems and Its Effects on Sensory, Cognitive, and Athletic Implications after Multiple Injections of Gadolinium-Based Contrast Agents in Rats.

Yao X, Hu J, Wang G, Lin X, Sun J, Dong G AJNR Am J Neuroradiol. 2024; 45(8):1153-1161.

PMID: 38991773 PMC: 11383410. DOI: 10.3174/ajnr.A8295.


Gadolinium Contrast Agent Deposition in Children.

Ouyang M, Bao L J Magn Reson Imaging. 2024; 61(1):70-82.

PMID: 38597340 PMC: 11645493. DOI: 10.1002/jmri.29389.


Revolutionizing lymph node metastasis imaging: the role of drug delivery systems and future perspectives.

Cai Z, Li Z, Zhong N, Cao L, Xiao Y, Li J J Nanobiotechnology. 2024; 22(1):135.

PMID: 38553735 PMC: 10979629. DOI: 10.1186/s12951-024-02408-5.